1. Home
  2. IFRX vs YTRA Comparison

IFRX vs YTRA Comparison

Compare IFRX & YTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IFRX
  • YTRA
  • Stock Information
  • Founded
  • IFRX 2007
  • YTRA 2005
  • Country
  • IFRX Germany
  • YTRA India
  • Employees
  • IFRX N/A
  • YTRA N/A
  • Industry
  • IFRX Biotechnology: Pharmaceutical Preparations
  • YTRA Transportation Services
  • Sector
  • IFRX Health Care
  • YTRA Consumer Discretionary
  • Exchange
  • IFRX Nasdaq
  • YTRA Nasdaq
  • Market Cap
  • IFRX 53.5M
  • YTRA 43.3M
  • IPO Year
  • IFRX 2017
  • YTRA N/A
  • Fundamental
  • Price
  • IFRX $0.87
  • YTRA $0.96
  • Analyst Decision
  • IFRX Strong Buy
  • YTRA Strong Buy
  • Analyst Count
  • IFRX 4
  • YTRA 1
  • Target Price
  • IFRX $7.75
  • YTRA $3.00
  • AVG Volume (30 Days)
  • IFRX 359.0K
  • YTRA 23.6K
  • Earning Date
  • IFRX 08-07-2025
  • YTRA 08-30-2025
  • Dividend Yield
  • IFRX N/A
  • YTRA N/A
  • EPS Growth
  • IFRX N/A
  • YTRA N/A
  • EPS
  • IFRX N/A
  • YTRA N/A
  • Revenue
  • IFRX $140,242.00
  • YTRA $93,125,316.00
  • Revenue This Year
  • IFRX N/A
  • YTRA N/A
  • Revenue Next Year
  • IFRX $1,276.37
  • YTRA N/A
  • P/E Ratio
  • IFRX N/A
  • YTRA N/A
  • Revenue Growth
  • IFRX 30.90
  • YTRA 89.92
  • 52 Week Low
  • IFRX $0.71
  • YTRA $0.58
  • 52 Week High
  • IFRX $2.82
  • YTRA $1.75
  • Technical
  • Relative Strength Index (RSI)
  • IFRX 45.31
  • YTRA 50.20
  • Support Level
  • IFRX $0.82
  • YTRA $0.94
  • Resistance Level
  • IFRX $0.93
  • YTRA $1.00
  • Average True Range (ATR)
  • IFRX 0.06
  • YTRA 0.03
  • MACD
  • IFRX 0.02
  • YTRA -0.01
  • Stochastic Oscillator
  • IFRX 33.94
  • YTRA 61.17

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

About YTRA Yatra Online Inc.

Yatra Online Inc is an Indian consumer travel platform provider and online travel agent. The company is organized into the following business segments; Air Ticketing which derives maximum revenue, Hotels and Packages, and Other Services. It mainly provides travel-related services, which include domestic and international air ticketing, hotel bookings, homestays, holiday packages, bus ticketing, rail ticketing, activities and ancillary services. It also involves hosting advertisements on its internet websites, the sale of rail and bus tickets, and facilitating website access to travel insurance companies. Some of its applications include Yatra Mini, Yatra Web Check-In, Yatra Corporate, and Travelguru HomeStay.

Share on Social Networks: